NASDAQ:ACON Aclarion (ACON) Stock Price, News & Analysis $0.19 -0.04 (-17.48%) (As of 10/23/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About Aclarion Stock (NASDAQ:ACON) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aclarion alerts:Sign Up Key Stats Today's Range$0.19▼$0.2250-Day Range$0.17▼$0.2552-Week Range$0.16▼$7.84Volume2.88 million shsAverage Volume1.55 million shsMarket Capitalization$1.55 millionP/E RatioN/ADividend YieldN/APrice Target$1.50Consensus RatingBuy Company OverviewAclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.Read More… Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Aclarion Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks65th Percentile Overall ScoreACON MarketRank™: Aclarion scored higher than 65% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAclarion has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageAclarion has only been the subject of 1 research reports in the past 90 days.Read more about Aclarion's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Aclarion are expected to grow in the coming year, from ($0.86) to ($0.73) per share.Read more about Aclarion's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.74% of the float of Aclarion has been sold short.Short Interest Ratio / Days to CoverAclarion has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aclarion has recently decreased by 6.54%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAclarion does not currently pay a dividend.Dividend GrowthAclarion does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.74% of the float of Aclarion has been sold short.Short Interest Ratio / Days to CoverAclarion has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aclarion has recently decreased by 6.54%, indicating that investor sentiment is improving significantly. News and Social MediaN/ANews SentimentN/A Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aclarion insiders have not sold or bought any company stock.Percentage Held by Insiders22.30% of the stock of Aclarion is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.52% of the stock of Aclarion is held by institutions.Read more about Aclarion's insider trading history. Receive ACON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter. Email Address ACON Stock News HeadlinesAclarion to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 10, 2024 | globenewswire.comAclarion’s Nociscan Technology Enhances Understanding of Modic Changes in Back Pain PatientsSeptember 30, 2024 | msn.comMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.October 24, 2024 | The Freeport Society (Ad)Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesSeptember 27, 2024 | globenewswire.comPRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI TechnologySeptember 13, 2024 | globenewswire.comAclarion, Inc.: Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesSeptember 12, 2024 | finanznachrichten.deAclarion Provides Corporate Update on Nociscan AI Technology MilestonesSeptember 12, 2024 | globenewswire.comAclarion, Inc.: Aclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialSeptember 10, 2024 | finanznachrichten.deSee More Headlines ACON Stock Analysis - Frequently Asked Questions How have ACON shares performed this year? Aclarion's stock was trading at $3.20 at the beginning of the year. Since then, ACON stock has decreased by 94.1% and is now trading at $0.1888. View the best growth stocks for 2024 here. How were Aclarion's earnings last quarter? Aclarion, Inc. (NASDAQ:ACON) posted its quarterly earnings data on Wednesday, August, 14th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.19) by $0.04. The company had revenue of $0.01 million for the quarter. Aclarion had a negative trailing twelve-month return on equity of 910.84% and a negative net margin of 10,967.15%. When did Aclarion's stock split? Aclarion shares reverse split on the morning of Thursday, January 4th 2024. The 1-16 reverse split was announced on Thursday, January 4th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 4th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split. When did Aclarion IPO? Aclarion (ACON) raised $12 million in an IPO on Friday, April 22nd 2022. The company issued 2,165,000 shares at $4.50-$6.50 per share. How do I buy shares of Aclarion? Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Aclarion own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aclarion investors own include Broadcom (AVGO), Meta Platforms (META), Norwegian Cruise Line (NCLH), AudioEye (AEYE), Advanced Micro Devices (AMD), ASML (ASML) and AvidXchange (AVDX). Company Calendar Last Earnings8/14/2024Today10/23/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolNASDAQ:ACON CUSIPN/A CIK1635077 Webwww.aclarion.com Phone833-275-2266FaxN/AEmployees7Year FoundedN/APrice Target and Rating Average Stock Price Target$1.50 High Stock Price Target$1.50 Low Stock Price Target$1.50 Potential Upside/Downside+694.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,910,000.00 Net Margins-10,967.15% Pretax Margin-10,967.15% Return on Equity-910.84% Return on Assets-218.13% Debt Debt-to-Equity RatioN/A Current Ratio1.28 Quick Ratio1.28 Sales & Book Value Annual Sales$53,947.00 Price / Sales28.71 Cash FlowN/A Price / Cash FlowN/A Book Value($0.38) per share Price / Book-0.50Miscellaneous Outstanding Shares8,203,000Free Float9,874,000Market Cap$1.55 million OptionableNot Optionable Beta0.43 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (NASDAQ:ACON) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored #1 Pre-IPO Opportunity For 2024 [Take Action Now!]According to James, the largest IPO in history could kick off in a matter of weeks. I’m talking about Starl...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.